| Trial ID: | L3343 |
| Source ID: | NCT01910441
|
| Associated Drug: |
Vildagliptin
|
| Title: |
Comparison of Vildagliptin vs. Glimepiride on Glucose Variability in Metformin Uncontrolled Type 2 Diabetic Patients
|
| Acronym: |
VARIABLE
|
| Status: |
TERMINATED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT01910441/results
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: Vildagliptin|DRUG: Glimepiride|DRUG: Metformin
|
| Outcome Measures: |
Primary: Mean Amplitude of Glycemic Excursions (MAGE), 16 weeks |
|
| Sponsor/Collaborators: |
Sponsor: Novartis Pharmaceuticals
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
95
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2013-07
|
| Completion Date: |
2014-09
|
| Results First Posted: |
2015-10-28
|
| Last Update Posted: |
2015-10-28
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT01910441
|
